touchNEUROLOGY had the pleasure to meet with Deena Kuruvilla (Westport Headache Institute, Westport, CT, USA) to discuss the Cefaly (External Trigeminal Nerve Stimulator) device as a non-pharmacological option for the prevention and acute treatment of migraine.
The abstract ‘A Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM)’ was presented at the American Headache Society (AHS) Virtual Annual Scientific Meeting 2021, 3-6 June 2021.
- Why is there a need for a non-pharmacological option for the prevention and acute treatment of migraine? (0:20)
- Could you tell us a little about the Cefaly device and the rationale for its use in this indication? (1:02)
- What clinical evidence supports the use of the Cefaly device? (1:48)
Disclosures: Deena Kuruvilla is a medical advisor for Cefaly.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed as a highlight of AHS 2021 (Virtual).
Share this Video
Related Videos In Headache Disorders
Stephanie Nahas, AHS 2021: HALO Long Term Study Results
We had the great pleasure of meeting with Stephanie Nahas (Thomas Jefferson University, Jefferson Headache Center, Philadelphia, PA, USA) to discuss the HALO long term extension study investigating long term efficacy and tolerability of fremanezumab in patients with episodic and chronic migraine. The abstract ‘Clinically Meaningful Responses to Fremanezumab Treatment in Episodic and Chronic Migraine […]
Stephanie Nahas, AHS 2021: Results from the CaMEO Study
We had the great pleasure of meeting with Stephanie Nahas (Thomas Jefferson University, Jefferson Headache Center, Philadelphia, PA, USA) to discuss the CaMEO results, a web-based survey to characterize self-reported use of preventive medications for migraine and treatment gaps. The abstract ‘Characterizing preventive treatment gaps in migraine: Results from the CaMEO study’ & ‘Optimal acute […]
Robert Shapiro, AHS 2021: COVID-19 Incidence and Mortality Among Individuals with Migraine
touchNEUROLOGY met with Robert Shapiro (Larner College of Medicine at the University of Vermont, Burlington, VT, USA) to discuss the impact of COVID-19 on individuals with migraine. The abstract ‘Migraine Is Associated With Higher Incidence of COVID-19, and Higher Frequency of COVID-19 Symptoms, but Lower COVID-19-Associated Health Care Resource Utilization Rates’ was presented at the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!